99 related articles for article (PubMed ID: 15653169)
21. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
[TBL] [Abstract][Full Text] [Related]
22. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
23. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
[TBL] [Abstract][Full Text] [Related]
24. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O
J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
[TBL] [Abstract][Full Text] [Related]
25. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
26. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice.
Little CS; Hammond CJ; MacIntyre A; Balin BJ; Appelt DM
Neurobiol Aging; 2004 Apr; 25(4):419-29. PubMed ID: 15013562
[TBL] [Abstract][Full Text] [Related]
27. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
Wozniak MA; Itzhaki RF; Shipley SJ; Dobson CB
Neurosci Lett; 2007 Dec; 429(2-3):95-100. PubMed ID: 17980964
[TBL] [Abstract][Full Text] [Related]
29. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
30. In situ Abeta pores in AD brain are cylindrical assembly of Abeta protofilaments.
Inoue S
Amyloid; 2008 Dec; 15(4):223-33. PubMed ID: 19065293
[TBL] [Abstract][Full Text] [Related]
31. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
[TBL] [Abstract][Full Text] [Related]
32. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.
Gervais F; Paquette J; Morissette C; Krzywkowski P; Yu M; Azzi M; Lacombe D; Kong X; Aman A; Laurin J; Szarek WA; Tremblay P
Neurobiol Aging; 2007 Apr; 28(4):537-47. PubMed ID: 16675063
[TBL] [Abstract][Full Text] [Related]
33. The development of amyloid beta protein deposits in the aged brain.
Thal DR; Capetillo-Zarate E; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2006 Mar; 2006(6):re1. PubMed ID: 16525193
[TBL] [Abstract][Full Text] [Related]
34. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice.
Lazarov O; Robinson J; Tang YP; Hairston IS; Korade-Mirnics Z; Lee VM; Hersh LB; Sapolsky RM; Mirnics K; Sisodia SS
Cell; 2005 Mar; 120(5):701-13. PubMed ID: 15766532
[TBL] [Abstract][Full Text] [Related]
35. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.
Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN
Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242
[TBL] [Abstract][Full Text] [Related]
36. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
38. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
40. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO
J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]